NASDAQ: TDACW Translational Development Acquisition Corp. 8-K

TDAC announces $3.8B merger with ProLogium, faces June 24 extension deadline

Filed May 27, 2026 · Period ending May 27, 2026 · ~1 min read

Key Changes

  • high

    TDAC entered into a definitive merger agreement with ProLogium on May 27, 2026, implying a $3.8 billion valuation. The deal requires shareholder approvals from both companies, Nasdaq listing approval, and minimum cash of $250 million after redemptions.

    Item 1.01: Business Combination Agreement verify on EDGAR →
  • high

    TDAC must extend its business combination deadline beyond June 24, 2026—less than one month away—or ProLogium can terminate the agreement. The deal must close by March 31, 2027, creating tight execution timelines and near-term risk.

    Item 1.01: Extension requirement verify on EDGAR →
  • medium

    ProLogium will reserve up to 2.5% of shares for the Founder as IP compensation and establish a 12.5% equity incentive pool, potentially diluting existing shareholders by up to 15% in aggregate after closing.

    Item 1.01: Founder IP and equity plan verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SJM 10-K) is open in full — no account needed.

Partner

Trade TDACW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · May 28, 2026 10:37 PM